Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients

NCT01314313 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT01314313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01314313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2011
Completion date
January 17, 2024
Enrollment
2,032 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe aortic stenosis